GSK plc (LON:GSK) Insider Wendy Becker Purchases 446 Shares

GSK plc (LON:GSK) insider Wendy Becker acquired 446 shares of GSK stock in a transaction dated Thursday, June 20th. The shares were acquired at an average price of GBX 1,614 ($20.51) per share, with a total value of £7,198.44 ($9,146.68).

GSK Trading Down 1.2 %

Shares of GSK stock opened at GBX 1,599 ($20.32) on Friday. The firm has a 50 day moving average price of GBX 1,689.20 and a two-hundred day moving average price of GBX 1,625.18. The company has a quick ratio of 0.73, a current ratio of 0.87 and a debt-to-equity ratio of 134.34. The company has a market capitalization of £65.24 billion, a PE ratio of 1,466.97, a price-to-earnings-growth ratio of 1.19 and a beta of 0.27. GSK plc has a 12-month low of GBX 1,302.60 ($16.55) and a 12-month high of GBX 1,823.50 ($23.17).

GSK Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Thursday, May 16th will be given a dividend of GBX 15 ($0.19) per share. The ex-dividend date is Thursday, May 16th. This represents a yield of 0.9%. GSK’s dividend payout ratio (DPR) is presently 5,504.59%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,950 ($24.78) price objective on shares of GSK in a research note on Tuesday. Barclays reiterated an “equal weight” rating and issued a GBX 1,725 ($21.92) target price on shares of GSK in a research note on Tuesday, May 7th. Shore Capital reiterated a “buy” rating on shares of GSK in a research note on Wednesday, June 12th. Finally, JPMorgan Chase & Co. reiterated an “underweight” rating on shares of GSK in a research note on Tuesday. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of GBX 1,675.63 ($21.29).

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.